Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced that the Company s product portfolio of FDA-approved brands delivered combined revenues of $9.2 million during the. | May 9, 2023
Company Also Delivers Growing Cash Flow from Operations
NASHVILLE, Tenn., Nov. 8, 2022 /PRNewswire/ Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, announced today that. | November 8, 2022
/PRNewswire/ Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved.
NASHVILLE, Tenn., Nov. 1, 2022 /PRNewswire/ Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), the largest, public biopharmaceutical company founded and headquartered in Tennessee, announced today that it has moved its headquarters